FDA approves Shire's constipation drug

FDA approves Shire's constipation drug

Submitted by admin on December 16, 2018 - 12:02am
Source: 
BioCentury
News Tags: 
FDA
Motegrity prucalopride
Chire
chronic idiopathic constipation
Headline: 
FDA approves Shire's constipation drug
snippet: 

FDA approved Motegrity prucalopride from Shire plc (LSE:SHP; NASDAQ:SHPG) to treat chronic idiopathic constipation (CIC) in adults. The approval came a week ahead of the drug's Dec. 21 PDUFA date.

Do Not Allow Advertisers to Use My Personal information